Expression of alternatively spliced Runx2 in multiple myeloma patients and a shift in expression in response to thalidomide treatment.

被引：0
|
作者：
Bose, N
Bergemann, H
Westendorf, JJ
Rajkumar, SV
Masellis, AM
机构：
[1] Virginia Piper Canc Inst, Minneapolis, MN USA
[2] Univ Minnesota, Orthopaed Surg & Canc Ctr, Minneapolis, MN 55455 USA
[3] Mayo Clin & Mayo Fdn, Rochester, MN 55905 USA
来源：
JOURNAL OF BONE AND MINERAL RESEARCH | 2003年 / 18卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S310 / S310
页数：1
相关论文
共 50 条
  • [31] RESPONSE TO VELCADE-THALIDOMIDE-DEXAMETHASONE (VTD) AS INDUCTION TERAPHY IN MULTIPLE MYELOMA PATIENTS CARRYING T(4;14): ANALYSIS OF GENE EXPRESSION PROFILE
    Terragna, C.
    Durante, S.
    Remondini, D.
    Martinelli, G.
    Testoni, N.
    Marzocchi, G.
    Perrone, G.
    Zamagni, E.
    Tacchetti, P.
    Tosi, P.
    Pantani, L.
    Patriarca, F.
    Petrucci, M.
    Galli, E.
    Di Raimondo, F.
    Boccadoro, M.
    Musto, P.
    Baccarani, M.
    Cavo, M.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 135 - 135
  • [32] Cooperation Between IL-7 and TNF-Alpha Results in Suppression of Runx2/Cbfal Expression and Inhibition of Osteoblast Differentiation in Myeloma
    Del Prete, Davide
    Yu, Shibing
    Xiao, Guozhi
    Roodman, David
    BLOOD, 2008, 112 (11) : 603 - 603
  • [33] Deficiency of blood dendritic cells in patients with multiple myeloma: Possible significance for prediction of response to first line treatment.
    Smolewski, Piotr
    Branicka, Agata
    Cebula, Barbara
    Urbanska-Rys, Halina
    Robak, Tadeusz
    BLOOD, 2006, 108 (11) : 347B - 347B
  • [34] Prognostic significance of BCL-2 expression in patients with multiple myeloma.
    Hashmi, M
    Kojouri, K
    Yang, J
    Patel, S
    Khan, M
    Sylvester-Kohrt, N
    Kamble, R
    Selby, GB
    Ozer, H
    Kharfan-Dabaja, MA
    BLOOD, 2004, 104 (11) : 292B - 293B
  • [35] Expression of MMP-2 and MMP-9 in patients with multiple myeloma
    Skliris, A.
    Labropoulou, V.
    Carina, S.
    Magne, B.
    Karamanos, N.
    Papageorgakopoulou, N.
    Theocharis, A.
    FEBS JOURNAL, 2008, 275 : 240 - 240
  • [36] Prolonged progression free survival does not relate to quality of response to treatment with thalidomide in patients with relapsed multiple myeloma (MM)
    Quach, Hang
    Prince, Miles H.
    Mileshkin, Linda
    Seymour, John F.
    Westerman, David
    Milner, Alvin D.
    BLOOD, 2007, 110 (11) : 798A - 798A
  • [37] Expression Of Runx2 And Osteoblast Cell On The Periodontal Of Diabetes Mellitus Wistar Rat With Diet Extract Lemuru Fish Oils Treatment
    Damaiyanti, W. D.
    Parisihni, K.
    Mulawarmanti, D.
    Kurniawan, H.
    Widyastuti
    12TH CONGRESS OF INDONESIAN SOC. FOR BIOCHEMISTRY AND MOLECULAR BIOLOGY IN CONJUNCTION WITH THE 2ND INT. CONF COLLABORATION SEMINAR OF CHEMISTRY AND INDUSTRY (COSCI) AND ANMICRO WORKSHOP, 2018, 2019, 217
  • [38] Complete Response to First-Line Bortezomib-Thalidomide-Dexamethasone Therapy in Multiple Myeloma Patients with t(4;14): Analysis of Gene Expression Profile
    Terragna, Carolina
    Durante, Sandra
    Remondini, Daniel
    Martinelli, Giovanni
    Patriarca, Francesca
    Petrucci, Maria Teresa
    Galli, Monica
    Di Raimondo, Francesco
    Crippa, Claudia
    Boccadoro, Mario
    Astolfi, Annalisa
    Testoni, Nicoletta
    Marzocchi, Giulia
    Derudas, Daniele
    Ballanti, Stelvio
    Pisani, Francesco
    Catania, Gioacchino
    Castagna, Luca
    Palmieri, Salvatore
    Califano, Catello
    Baraldi, Anna
    Grasso, Mariella
    Musto, Pellegrino
    Brioli, Annamaria
    Baccarani, Michele
    Cavo, Michele
    BLOOD, 2009, 114 (22) : 1099 - 1099
  • [39] Thalidomide-based induction regimens are as effective as bortezomib-based regimens in elderly patients with multiple myeloma with cereblon expression
    Sung-Hoon Jung
    Hyun-Jung Choi
    Myung-Geun Shin
    Seung-Shin Lee
    Eu Chang Hwang
    Tae-Young Jung
    Min-Seok Cho
    Deok-Hwan Yang
    Jae-Sook Ahn
    Yeo-Kyeoung Kim
    Hyeoung-Joon Kim
    Je-Jung Lee
    Annals of Hematology, 2016, 95 : 1645 - 1651
  • [40] Thalidomide-based induction regimens are as effective as bortezomib-based regimens in elderly patients with multiple myeloma with cereblon expression
    Jung, Sung-Hoon
    Choi, Hyun-Jung
    Shin, Myung-Geun
    Lee, Seung-Shin
    Hwang, Eu Chang
    Jung, Tae-Young
    Cho, Min-Seok
    Yang, Deok-Hwan
    Ahn, Jae-Sook
    Kim, Yeo-Kyeoung
    Kim, Hyeoung-Joon
    Lee, Je-Jung
    ANNALS OF HEMATOLOGY, 2016, 95 (10) : 1645 - 1651
12345